Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

ObjectiveTo obtain real-world data on outcomes of belimumab treatment and respective prognostic factors in patients with systemic lupus erythematosus (SLE).MethodsObservational study of 188 active SLE patients (median disease duration 6.2 years, two previous immunosuppressive/biological agents) trea...

Full description

Bibliographic Details
Main Authors: Myrto Nikoloudaki, Dionysis Nikolopoulos, Sofia Koutsoviti, Irini Flouri, Noemin Kapsala, Argyro Repa, Pelagia Katsimbri, Evangelos Theotikos, Sofia Pitsigavdaki, Katerina Pateromichelaki, Antonios Bertsias, Antonia Elezoglou, Prodromos Sidiropoulos, Antonis Fanouriakis, Dimitrios Boumpas, George Bertsias
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
lupus
low disease activity
remission
flares
organ damage
biologics
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1074044/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1074044/full

Similar Items